FRI0098 The Safety and Treatment Efficacy of Abatacept in Rheumatoid Arthritis Patients with Interstitial Lung Disease: From the Tsurumai Biologics Communication Registry (TBCR) Multicenter Study

S. Hirabara; T. Kojima; N. Takahashi; A. Kaneko; D. Kida; Y. Hirano; N. Ishiguro

doi:10.1136/annrheumdis-2015-eular.1365

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Alerts

Poster Presentations

Rheumatoid arthritis - comorbidity and clinical aspects

FRI0098 The Safety and Treatment Efficacy of Abatacept in Rheumatoid Arthritis Patients with Interstitial Lung Disease: From the Tsurumai Biologics Communication Registry (TBCR) Multicenter Study

Log in using your username and password

Main menu

Log in using your username and password

You are here

Read the full text or download the PDF:

Log in using your username and password